Ultrastructural evidence for a role of γ‐aminobutyric acid in mediating the effects of corticotropin‐releasing factor on the rat dorsal raphe serotonin system
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The dorsal raphe nucleus (DRN) serotonin (5‐HT) system has been implicated in acute responses to stress and in stress‐related psychiatric disorders such as anxiety and depression. Substantial findings suggest that the neuropeptide corticotropin‐releasing factor (CRF) is instrumental in modulating the activity of this system during stress. Because the DRN is neurochemically heterogeneous, dual immunoelectron microscopy was used to examine cellular substrates for interactions between CRF and either 5‐HT or γ‐aminobutyric acid (GABA) in the dorsolateral and ventromedial DRN. CRF immunoreactivity was identified primarily within axon terminals, where immunolabeling was particularly enriched in dense‐core vesicles. Although CRF terminals targeted 5‐HT‐containing dendrites in the dorsolateral DRN (16%; n = 251 terminals), synaptic contacts with dendrites that lacked detectable 5‐HT immunolabeling were more numerous (48%). In contrast, dual labeling for CRF and GABA (n = 240 terminals) in the dorsolateral DRN revealed that substantially more CRF terminals contacted GABA dendrites (42%) as opposed to unlabeled dendrites (29%). In the ventromedial DRN, contacts between CRF axon terminals and either 5‐HT‐labeled dendrites or GABA‐containing dendrites were fewer than in the dorsolateral DRN. As in the dorsolateral DRN, CRF terminals more frequently contacted GABA dendrites than 5‐HT dendrites (30% vs. 8%, respectively). The findings support physiological studies suggesting that CRF has both direct and indirect effects on DRN‐5‐HT neurons and further implicate GABA as a primary mediator by which CRF and stressors alter the activity of the DRN‐5‐HT system. J. Comp. Neurol. 482:155–165, 2005. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953 · cited 2×
“In support of this, CRF terminals, along with CRF receptor binding sites and CRF receptor mRNA, are widely distributed in extrahypophyseal brain regions (Swanson et al., 1983; De Souza, 1987; Sakanaka et al., 1987; Chalmers et al., 1995).”
BackgroundCaldji, C., Tannenbaum, B., Sharma, S., Francis, D., Plotsky, P. M., & Meaney, M. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5335 · Cited by 1,437
Pet imaging of serotonin 1A receptor binding in depression
Drevets, W. C., Frank, E., Price, J. C., Kupfer, D. J., Holt, D., Greer, P. J., Huang, Y., Gautier, C., & Mathis, C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00189-4 · Cited by 666 · cited 1×
“Enhanced CRF tone to the DRN may underlie serotonergic dysfunctions that have been documented by numerous end points in depressed subjects (Stockmeier et al., 1998; Drevets et al., 1999; Arango et al., 2001).”
BackgroundArango, V (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00310-4 · Cited by 368
Lowry, C. A., Rodda, J. E., Lightman, S. L., & Ingram, C. D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07728.2000 · Cited by 211 · cited 2×
“CRF and its related peptide, urocortin II, alter DRN neuronal activity in vivo in anesthetized rats and in vitro in rat DRN slices (Kirby et al., 2000; Lowry et al., 2000; Pernar et al., 2004).”
BackgroundJankowski, M. P., & Sesack, S. R. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.10976 · Cited by 186
Austin, M. C., Janosky, J. E., & Murphy, H. A. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001250 · Cited by 162 · cited 1×
“CRF densely innervates the human DRN (Ruggiero et al., 1999), and CRF immunoreactivity in the DRN is increased in depressed male suicide subjects (Austin et al., 2003).”
Background
Cited by
Hauger, R., Risbrough, V., Brauns, O., & Dautzenberg, F. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706777950684 · Cited by 343
ANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337
Calizo, L. H., Akanwa, A., Ma, X., Pan, Y.-Z., Lemos, J. C., Craige, C., Heemstra, L. A., & Beck, S. G. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.008 · Cited by 252
“, 2003), and in mediating the actions of the stress hormone CRF in this region (Waselus et al., 2005).”
Lukkes, J. L. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.018.2009 · Cited by 235
Glucocorticoids, chronic stress, and obesity
Dallman, M. F., Pecoraro, N. C., La Fleur, S. E., Warne, J. P., Ginsberg, A. B., Akana, S. F., Laugero, K. C., Houshyar, H., Strack, A. M., Bhatnagar, S., et al. (2006) · Progress in Brain Research · doi:10.1016/s0079-6123(06)53004-3 · Cited by 198
Metadata
- Authors
- Waselus, M., Valentino, R. J., & Van Bockstaele, E. J.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 2004-12-20
- Volume
- 482
- Issue
- 2
- Pages
- 155-165
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2063693395
- Cited by
- 63
- References
- 7
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.